MicroRNA (miR) dysregulation during

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

1. Mechanisms of chemoresistance in gastric cancer: interplay between microRNAs and the tumor microenvironment.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
   Review
2. MicroRNAs as Orchestrators of Immune Responses to Bacterial Infection.Microorganisms · 2026
   Review
3. Hypoxia Signaling and Non-Coding RNAs: Regulatory Networks and Therapeutic Implications in Breast Cancer.Current issues in molecular biology · 2026
   Review
4. Interplay Between Dysregulated Immune System and the Footprints of Blood-Borne miRNAs in Treatment Naive Crohn's Disease and Ulcerative Colitis Patients.International journal of molecular sciences · 2025
   Article
5. Exosomes and their role in gastric cancer caused by Helicobacter pylori.Molecular biology reports · 2025
   Review
6. Mechanism of crosstalk between Helicobacter pylori and immune stromal cells in the development and occurrence of gastric cancer.Discover oncology · 2025
   Review
7. Epigenetic alterations inJournal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2025
   Review
8. Unraveling the interplay of CD8 + T cells and microRNA signaling in cancer: implications for immune dysfunction and therapeutic approaches.Journal of translational medicine · 2024
   Review
9. MicroRNA-155 and its exosomal form: Small pieces in the gastrointestinal cancers puzzle.Cell biology and toxicology · 2024
   Review
10. Non-coding RNAs as therapeutic targets in cancer and its clinical application.Journal of pharmaceutical analysis · 2024
    Review
11. Epigenetic modifications: Key players in cancer heterogeneity and drug resistance.Translational oncology · 2024
    Article
12. Potential Non-invasive Biomarkers of Helicobacter pylori-Associated Gastric Cancer.Journal of gastrointestinal cancer · 2022
    Review
13. Emerging Role of microRNA Dysregulation in Diagnosis and Prognosis of Extrahepatic Cholangiocarcinoma.Genes · 2022
    Review
14. Expression analysis of miRNA-155 level inIranian journal of microbiology · 2022
    Article
15. Performance of DNA Methylation on the Molecular Pathogenesis ofJournal of pharmacopuncture · 2022
    Review
16. Differential Expression of Tissular miRNA-155 in Pediatric Gastritis.Journal of clinical medicine · 2022
    Article
17. Helicobacter pylori Infection Mediates Inflammation and Tumorigenesis-Associated Genes Through miR-155-5p: An Integrative Omics and Bioinformatics-Based Investigation.Current microbiology · 2022
    Article
18. Non-coding RNA in cancer.Essays in biochemistry · 2021
    Review
19. MicroRNA Changes in Gastric Carcinogenesis: Differential Dysregulation duringGenes · 2021
    Review
20. Effects ofTranslational cancer research · 2020
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as